OU749

CAS No. 519170-13-9

OU749( —— )

Catalog No. M27513 CAS No. 519170-13-9

OU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 61 In Stock
2MG 40 In Stock
5MG 77 In Stock
10MG 123 In Stock
25MG 208 In Stock
50MG 303 In Stock
100MG 451 In Stock
200MG Get Quote In Stock
500MG 986 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    OU749
  • Note
    Research use only, not for human use.
  • Brief Description
    OU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.
  • Description
    OU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    TNF-α|PGE|p38|Mitochondrial Metabolism|PTEN-induced kinase 1 (PINK1)|Bacterial|Autophagy
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    519170-13-9
  • Formula Weight
    361.43
  • Molecular Formula
    C16H15N3O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (345.84 mM)
  • SMILES
    COc1ccc(Cc2nnc(NS(=O)(=O)c3ccccc3)s2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shin SW, et al. Antagonizing effects and mechanisms of afzelin against UVB-induced cell damage. PLoS One. 2013 Apr 23;8(4):e61971.
molnova catalog
related products
  • Pradigastat

    Pradigastat (LCQ-908) is an orally active, potent and selective diacylglycerol acyltransferase 1 (DGAT1) inhibitor for the treatment of constipation, which may be used in the study of obesity and diabetes.

  • histidine

    Histidine is a semi-essential amino acid (children should obtain it from food) needed in humans for growth and tissue repair.

  • GGTI-2133

    GGTI-2133 is a potent mimetic peptidyl geranylgeranyltransferase type I inhibitor (GGTase I) with an IC50 value of 38 nM.GGTI-2133 inhibits the invasion of inflammatory cells into the airways in experimental asthma in mice.